MedPath

VANFLYTA

VANFLYTA

Approved
DIN Number

02558378

Drug Class

Human

Market Date

N/A

Company
HC

daiichi sankyo pharma canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02558378
AIG Number0066987001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EX11 QUIZARTINIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

QUIZARTINIB (QUIZARTINIB HYDROCHLORIDE)Active
Strength: 26.5 MG
Monograph: QUIZARTINIB (QUIZARTINIB HYDROCHLORIDE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.